Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v2.4.0.8
Consolidated Statements of Operations (USD $)
12 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Revenues $ 0 $ 0
Operating expenses:    
General and administrative expenses 3,134,285 1,526,075
Research and development expenses 1,477,479 218,901
Total operating expenses 4,611,764 1,744,976
Operating loss (4,611,764) (1,744,976)
Other (expense) income:    
Interest expense (111,059) (108,879)
Loss on issuance of warrants (7,541,693) 0
Adjustment to fair value of derivative 4,121,693 0
Other income 0 64
Total other expense (3,531,059) (108,815)
Net Loss $ (8,142,823) $ (1,853,791)
Basic earnings per share    
Net Loss per Share $ (0.12) $ (0.09)
Weighted Common Shares - Basic and Diluted 67,492,823 21,366,752